1. Integrating network pharmacology with molecular docking to rationalize the ethnomedicinal use of Alchornea laxiflora (Benth.) Pax & K. Hoffm. for efficient treatment of depression
   Nem Kumar Jain et al, 2024, Frontiers in Pharmacology CrossRef
2. The antidepressive mechanism of Longya Lilium combined with Fluoxetine in mice with depression-like behaviors
   Huina Ma et al, 2024, npj Systems Biology and Applications CrossRef
3. Innate lymphoid cells in depression: Current status and perspectives
   Amit Kumar Madeshiya et al, 2022, Biomarkers in Neuropsychiatry CrossRef
4. Physiological and cognitive changes after treatments of cyclophosphamide, methotrexate, and fluorouracil: implications of the gut microbiome and depressive-like behavior
   Christa Corley et al, 2023, Frontiers in Neuroscience CrossRef
5. Depresssion, anxiety and other cognitive consequences of social isolation: Drug and non‐drug treatments
   Zahra Taheri Zadeh et al, 2021, International Journal of Clinical Practice CrossRef
6. Pyrimidine-based anticancer drugs
   Galal H. Elgemeie et al, 2022, New Strategies Targeting Cancer Metabolism CrossRef
7. The effect and mechanism of Jiao-tai-wan in the treatment of diabetes mellitus with depression based on network pharmacology and experimental analysis
   Yueheng Tang et al, 2021, Molecular Medicine CrossRef
8. Proprietary Medicines Containing Bupleurum chinense DC. (Chaihu) for Depression: Network Meta-Analysis and Network Pharmacology Prediction
   Qiao-feng Li et al, 2022, Frontiers in Pharmacology CrossRef
9. The Roles of IL-22 and Its Receptor in the Regulation of Inflammatory Responses in the Brain
   Dahae Lee et al, 2022, International Journal of Molecular Sciences CrossRef